Objective:

The article examines the objective, findings, and clinical context described in How Molecular Diagnostics Are Transforming Pathogen Detection When Cultures Are Negative.

Approach:

• Clinical context: A reported case of Legionella dumoffii bioprosthetic aortic valve endocarditis illustrates how plasma microbial cell-free DNA sequencing can identify a pathogen after conventional testing is unrevealing.
• Diagnostic methods: The article reviews plasma microbial cell-free DNA sequencing and 16S rRNA gene PCR/sequencing, including their use in endocarditis and their incorporation into the 2023 Duke–International Society for Cardiovascular Infectious Diseases criteria.

Key Findings:

• Blood cultures fail to identify a pathogen in an estimated 2.5% to 31% of endocarditis cases; fastidious and intracellular organisms are common causes.
• Plasma microbial cell-free DNA sequencing is hypothesis-free and may remain detectable longer after antibiotics than blood cultures: median positivity was approximately 38 days versus 3.7 days in a prospective study.
• In a retrospective cohort of 141 patients evaluated for suspected endocarditis, sequencing detected a pathogen in 60.6% of confirmed cases; it was the sole positive microbiological test in one third of those cases and prompted antimicrobial modification in hal…
• In routine practice, valve-tissue 16S PCR/Sanger sequencing was positive in 75% of cases, compared with 55% for blood cultures; among patients receiving antibiotics, the rates were 76% and 11%, respectively.
• A comparison found similar detection rates for targeted metagenomic sequencing and plasma microbial cell-free DNA sequencing; combined with blood cultures, the methods identified a likely pathogen in 97% of cases, including 5 of 6 culture-negative cases.

Interpretation:

The article presents molecular methods as complements to conventional microbiology for identifying pathogens in culture-negative endocarditis. It emphasizes that results require clinical interpretation and appropriate patient selection.

Limitations:

• About 29% of patients who ultimately lack an endocarditis diagnosis had clinically insignificant detections in one study.
• Plasma microbial cell-free DNA sequencing does not provide phenotypic antimicrobial susceptibility, is costly, and is available through only one reference laboratory.
• Consensus is lacking on a cutoff for clinical significance; microbial abundance alone should not direct clinical decisions.
• 16S-based methods are limited to bacteria, or fungi when 18S/ITS targets are used; blood sensitivity is lower than tissue sensitivity, and contamination remains a concern.

Sources:

• Article context supplied by the user